Equatorial Guinea vs Timor-Leste: Amphetamine use disorder deaths by sex
Equatorial Guinea
0.02 deaths
in 2021
Timor-Leste
0.02 deaths
in 2021
Equatorial Guinea rank
137th
Timor-Leste rank
137th
Amphetamine use disorder deaths by sex over time
- Equatorial Guinea
- Timor-Leste
How they compare
Equatorial Guinea currently reports 0.02 deaths against 0.02 deaths in Timor-Leste, a difference of 0 deaths.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Timor-Leste ahead.
Equatorial Guinea ranks 137th and Timor-Leste ranks 137th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.01 deaths | 0.01 deaths | 0 deaths | — |
| 2010s | 0.024 deaths | 0.011 deaths | 0.013 deaths | Equatorial Guinea |
| 2020s | 0.025 deaths | 0.015 deaths | 0.01 deaths | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder deaths by sex, Equatorial Guinea or Timor-Leste?
- Equatorial Guinea, at 0.02 deaths against 0.02 deaths in Timor-Leste as of 2021.
- What is the difference in amphetamine use disorder deaths by sex between Equatorial Guinea and Timor-Leste?
- 0 deaths, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Timor-Leste?
- 22 years are reported by both, from 2000 to 2021.
- How do Equatorial Guinea and Timor-Leste rank globally for amphetamine use disorder deaths by sex?
- Equatorial Guinea ranks 137th and Timor-Leste ranks 137th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in females.